Tadataka (Tachi) Yamada, M.D., serves as a Venture Partner with Frazier Healthcare Partners and serves as a Director of Agilent Technologies, CSL, and a number of private life sciences companies. As a member of the Frazier Life Sciences team, Dr. Yamada focuses on both creating companies as well as providing strategic guidance to existing portfolio companies.
Dr. Yamada was previously Chief Medical Officer and Chief Scientific Officer at Takeda Pharmaceuticals and a member of the company’s Board of Directors. In this role, Dr. Yamada was responsible for all of Takeda’s research and development activities and a budget of nearly $4 billion. Prior to Takeda, Dr. Yamada was President of the Bill & Melinda Gates Foundation Global Health Program in Seattle, where he oversaw over $9 billion in grants for applying technologies to address major health challenges of the developing world. Before joining the Gates Foundation, he was Chairman of Research and Development at GlaxoSmithKline and member of the Board of Directors. Dr. Yamada was the Chief of the Division of Gastroenterology and the Chair of the Department of Internal Medicine at the University of Michigan in Ann Arbor.
Dr. Yamada earned his M.D. from New York University School of Medicine and a B.A. in History from Stanford University. He has authored more 150 manuscripts in peer reviewed journals and is the editor of The Textbook of Gastroenterology.